Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 55,977 shares at $2.06 ($114K) on 2016-04-22, disclosed to the SEC on 2016-04-26.
Open-market sale of $114k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.06 | 3,041 | $6K | 5.5% |
| 2 | $2.07 | 100 | $207 | 0.2% |
| 3 | $2.07 | 19,759 | $41K | 35.8% |
| 4 | $2.07 | 100 | $207 | 0.2% |
| 5 | $2.08 | 1,000 | $2K | 1.8% |
| 6 | $2.08 | 1,000 |
| $2K |
| 1.8% |
| 7 | $2.08 | 3,692 | $8K | 6.7% |
| 8 | $2.09 | 100 | $209 | 0.2% |
| 9 | $2.00 | 1,800 | $4K | 3.2% |
| 10 | $2.00 | 200 | $400 | 0.4% |
| 11 | $2.00 | 200 | $401 | 0.4% |
| 12 | $2.00 | 500 | $1K | 0.9% |
| 13 | $2.01 | 400 | $804 | 0.7% |
| 14 | $2.01 | 500 | $1K | 0.9% |
| 15 | $2.01 | 7,600 | $15K | 13.4% |
| 16 | $2.01 | 400 | $805 | 0.7% |
| 17 | $2.02 | 1,200 | $2K | 2.1% |
| 18 | $2.02 | 1,200 | $2K | 2.1% |
| 19 | $2.02 | 877 | $2K | 1.6% |
| 20 | $2.05 | 3,400 | $7K | 6.1% |
| 21 | $2.06 | 2,408 | $5K | 4.3% |
| 22 | $1.95 | 4,000 | $8K | 6.8% |
| 23 | $1.97 | 2,500 | $5K | 4.3% |
| Total | $2.04 avg | 55,977 | $114K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |